SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood.
Ng DL, Goldgof GM, Shy BR, Levine AG, Balcerek J, Bapat SP, Prostko J, Rodgers M, Coller K, Pearce S, Franz S, Du L, Stone M, Pillai SK, Sotomayor-Gonzalez A, Servellita V, Martin CSS, Granados A, Glasner DR, Han LM, Truong K, Akagi N, Nguyen DN, Neumann NM, Qazi D, Hsu E, Gu W, Santos YA, Custer B, Green V, Williamson P, Hills NK, Lu CM, Whitman JD, Stramer SL, Wang C, Reyes K, Hakim JMC, Sujishi K, Alazzeh F, Pham L, Thornborrow E, Oon CY, Miller S, Kurtz T, Simmons G, Hackett J Jr, Busch MP, Chiu CY.
Ng DL, et al. Among authors: hackett j jr.
Nat Commun. 2020 Sep 17;11(1):4698. doi: 10.1038/s41467-020-18468-8.
Nat Commun. 2020.
PMID: 32943630
Free PMC article.